GC Cell Corporation
Research GC Cell Corporation (144510.KQ) on Bullrun: market cap KRW 201.66B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker144510.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 201.66B
- Financial periodQ2 2026
- RevenueKRW 41.60B
- Net incomeKRW 2.37B
- Free cash flow-KRW 2.63B
- Gross margin21.4%
Valuation Snapshot
latest market cap is KRW 201.66B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 201.66B | n/a | n/a | n/a |
About GC Cell Corporation
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GC Cell Corporation's market cap?
GC Cell Corporation's market capitalization is KRW 201.66B.
What does GC Cell Corporation do?
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.